BALDUZZI, SILVIA
 Distribuzione geografica
Continente #
NA - Nord America 292
EU - Europa 169
AS - Asia 78
SA - Sud America 1
Totale 540
Nazione #
US - Stati Uniti d'America 291
IE - Irlanda 107
CN - Cina 67
IT - Italia 23
DE - Germania 13
FI - Finlandia 13
SG - Singapore 10
BE - Belgio 4
CZ - Repubblica Ceca 3
RU - Federazione Russa 2
SE - Svezia 2
BR - Brasile 1
CA - Canada 1
GB - Regno Unito 1
IR - Iran 1
RO - Romania 1
Totale 540
Città #
Dublin 105
Chandler 70
Ashburn 51
Shanghai 18
Lawrence 13
Medford 13
Princeton 13
Helsinki 12
Nanjing 12
New York 12
Beijing 10
Washington 9
Singapore 8
Wilmington 5
Brussels 4
Galliate 4
Nanchang 4
Norwalk 4
Seattle 4
Brno 3
Changsha 3
Guangzhou 3
Los Angeles 3
Milan 3
Pavia 3
Ann Arbor 2
Berlin 2
Fairfield 2
Hebei 2
Jacksonville 2
Jiaxing 2
Matera 2
Monzambano 2
Shenyang 2
Shijiazhuang 2
Woodbridge 2
Chicago 1
Gunzenhausen 1
Haikou 1
Hangzhou 1
London 1
Messina 1
Philadelphia 1
Piscataway 1
Saint Petersburg 1
Serramanna 1
Toronto 1
Wuhan 1
Totale 423
Nome #
Clinical follow-up predictors of disease pattern change in anti-Jo1 positive anti-synthetase syndrome: Results from a multicenter, international and retrospective study 51
Methotrexate and glucocorticoids, but not anticytokine therapy, impair the immunogenicity of a single dose of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic inflammatory arthritis 51
In early inflammatory polyarthritis more intensive management according to the 2010 ACR/EULAR criteria leads to higher rates of clinical remission: Comparison of two cohorts treated according to different treat to target protocols 50
Correspondence on 'EULAR December 2020 viewpoints on SARS-CoV-2 vaccination in patients with RMDs' 45
Reactogenicity, safety and disease flares following BNT162b2 mRNA COVID-19 vaccine in patients with chronic immune-inflammatory arthritis treated with biological and targeted synthetic disease-modifying anti-rheumatic drugs 42
Preliminary Validation of the Digital Ulcer Clinical Assessment Score in Systemic Sclerosis 39
The role of extra-corporeal membrane oxygenation (ECMO) in the treatment of diffuse alveolar haemorrhage secondary to ANCA-associated vasculitis: report of two cases and review of the literature 39
Impact of smoking habit on adult-onset Still’s disease prognosis, findings from a multicentre observational study 37
Disparities in the prevalence of clinical features between systemic juvenile idiopathic arthritis and adult-onset Still's disease 35
Prevalence of COVID infections in a population of rheumatic patients from Lombardy and Marche treated with biological drugs or small molecules: A multicentre retrospective study 33
Retention rate of IL-1 inhibitors in Schnitzler's syndrome 33
Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies 30
Use of rituximab in a multicentre cohort of patients with rheumatic diseases during the outbreak of novel SARS-COV-2 infection 28
Incidence of COVID-19 in patients with rheumatic diseases treated with targeted immunosuppressive drugs: what can we learn from observational data? 25
Impact of smoking habit on adult-onset Still's disease prognosis, findings from a multicentre observational study 18
Correction to: Impact of smoking habit on adult-onset Still's disease prognosis, findings from a multicentre observational study 8
Retention rate of a second line with a biologic DMARD after failure of a first-line therapy with abatacept, tocilizumab, or rituximab: results from the Italian GISEA registry 6
Totale 570
Categoria #
all - tutte 2.949
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.949


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202038 12 14 0 0 0 0 0 1 1 5 5 0
2020/202114 0 0 1 0 0 0 1 3 4 0 4 1
2021/202258 0 0 3 1 5 2 2 4 1 2 8 30
2022/2023253 24 26 1 9 15 19 0 14 120 1 9 15
2023/2024185 17 25 12 8 23 47 6 16 5 17 4 5
2024/202510 10 0 0 0 0 0 0 0 0 0 0 0
Totale 570